Trial Profile
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATION.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Transplant rejection
- Focus Adverse reactions
- 20 Oct 2010 New trial record